MAFM
CRL icon

Mid Atlantic Financial Management’s Charles River Laboratories CRL Stock Holding History

Mid Atlantic Financial Management’s Portfolio CRL Stock Details CRL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-587
Closed -$217K – 920
2021
Q2 		$217K Buy
+587
New +$196K 0.01% 808

Other funds holding CRL

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Kayne Anderson Rudnick Investment Management
Kayne Anderson Rudnick Investment Management Los Angeles, California $34B AUM 6.31% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Mid Atlantic Financial Management's CRL Position: Q3 2021 in Review

Mid Atlantic Financial Management sold out of Charles River Laboratories (CRL) in Q3 2021, closing a stake of 587 shares — an estimated $217K sold.

Mid Atlantic Financial Management first reported a position in CRL in Q2 2021 and held it in 1 quarter. The position peaked at $217K in Q2 2021. 677 funds tracked by Wall St. Rank hold CRL as of Q3 2021.

  • Mid Atlantic Financial Management reported no remaining Charles River Laboratories position as of Q3 2021 after selling out during the quarter.
  • Mid Atlantic Financial Management sold 587 Charles River Laboratories shares in Q3 2021, an estimated $217K.
  • Mid Atlantic Financial Management first reported a position in Charles River Laboratories in Q2 2021 and held it in 1 quarter.
  • Mid Atlantic Financial Management's Charles River Laboratories position peaked at $217K in Q2 2021.
  • 677 funds tracked by Wall St. Rank held Charles River Laboratories as of Q3 2021.

Based on Mid Atlantic Financial Management's 13F filing for Q3 2021, filed 12 Nov 2021.